IL99829A - Heteroaroyl derivatives of monocyclic beta-lactams pharmaceutical compositions containing the same and processes for the preparation thereof - Google Patents

Heteroaroyl derivatives of monocyclic beta-lactams pharmaceutical compositions containing the same and processes for the preparation thereof

Info

Publication number
IL99829A
IL99829A IL9982991A IL9982991A IL99829A IL 99829 A IL99829 A IL 99829A IL 9982991 A IL9982991 A IL 9982991A IL 9982991 A IL9982991 A IL 9982991A IL 99829 A IL99829 A IL 99829A
Authority
IL
Israel
Prior art keywords
lactams
processes
preparation
pharmaceutical compositions
same
Prior art date
Application number
IL9982991A
Other languages
English (en)
Other versions
IL99829A0 (en
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Priority to IL118368A priority Critical patent/IL118368A/xx
Priority to IL11836796A priority patent/IL118367A0/xx
Publication of IL99829A0 publication Critical patent/IL99829A0/xx
Publication of IL99829A publication Critical patent/IL99829A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/42Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • C07C217/86Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/66Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9982991A 1990-11-05 1991-10-23 Heteroaroyl derivatives of monocyclic beta-lactams pharmaceutical compositions containing the same and processes for the preparation thereof IL99829A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL118368A IL118368A (en) 1990-11-05 1991-10-23 N-oxide quinoxaline derivatives
IL11836796A IL118367A0 (en) 1990-11-05 1991-10-23 Heteroaroyl derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60894590A 1990-11-05 1990-11-05

Publications (2)

Publication Number Publication Date
IL99829A0 IL99829A0 (en) 1992-08-18
IL99829A true IL99829A (en) 1997-01-10

Family

ID=24438745

Family Applications (3)

Application Number Title Priority Date Filing Date
IL11836796A IL118367A0 (en) 1990-11-05 1991-10-23 Heteroaroyl derivatives
IL118368A IL118368A (en) 1990-11-05 1991-10-23 N-oxide quinoxaline derivatives
IL9982991A IL99829A (en) 1990-11-05 1991-10-23 Heteroaroyl derivatives of monocyclic beta-lactams pharmaceutical compositions containing the same and processes for the preparation thereof

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL11836796A IL118367A0 (en) 1990-11-05 1991-10-23 Heteroaroyl derivatives
IL118368A IL118368A (en) 1990-11-05 1991-10-23 N-oxide quinoxaline derivatives

Country Status (27)

Country Link
US (3) US5290929A (fi)
EP (1) EP0484881B1 (fi)
JP (2) JP3157565B2 (fi)
KR (4) KR100210631B1 (fi)
CN (3) CN1159303C (fi)
AT (1) ATE178604T1 (fi)
AU (2) AU648835B2 (fi)
CA (1) CA2053359C (fi)
CZ (1) CZ289671B6 (fi)
DE (1) DE69131090T2 (fi)
DK (1) DK0484881T3 (fi)
ES (1) ES2129397T3 (fi)
FI (1) FI915194A (fi)
GR (1) GR3030572T3 (fi)
HU (1) HU211402B (fi)
IE (1) IE913565A1 (fi)
IL (3) IL118367A0 (fi)
MX (1) MX9101767A (fi)
MY (2) MY107454A (fi)
NO (1) NO914320L (fi)
NZ (5) NZ260513A (fi)
PL (1) PL167312B1 (fi)
PT (1) PT99427A (fi)
SK (1) SK282124B6 (fi)
UY (1) UY23318A1 (fi)
YU (1) YU175791A (fi)
ZA (1) ZA918014B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
US5888998A (en) * 1997-04-24 1999-03-30 Synphar Laboratories, Inc. 2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
US5994340A (en) * 1997-08-29 1999-11-30 Synphar Laboratories, Inc. Azetidinone derivatives as β-lactamase inhibitors
KR100702878B1 (ko) * 1999-10-29 2007-04-04 넥타르 테라퓨틱스 개선된 분산성을 갖는 건조 분말 조성물
US20030133925A1 (en) * 2001-09-28 2003-07-17 Shawar Ribhi M. Monobactam compositions and methods of use thereof
CN102988362B (zh) * 2005-12-07 2014-11-05 巴斯利尔药物股份公司 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103896964B (zh) * 2014-03-31 2016-04-13 南京工业大学 一类头孢中间体的制备方法
KR101583937B1 (ko) * 2014-06-09 2016-01-08 현대자동차주식회사 자동차용 연료센더 장치
CN105017167B (zh) * 2015-07-20 2017-10-20 新乡医学院 一种喹喔啉类化合物的制备方法
MX2019007613A (es) 2016-12-21 2019-09-04 Aicuris Gmbh & Co Kg Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos.
CN111511737B (zh) 2018-01-29 2022-10-18 南京明德新药研发有限公司 用于治疗细菌感染的单环β-内酰胺化合物
US20230022708A1 (en) 2019-12-19 2023-01-26 Medshine Discovery Inc. Application of compound in drug preparation
AU2022391635A1 (en) * 2021-11-18 2024-05-16 Merck Sharp & Dohme Llc Chromane amidine monobactam antibiotics

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1408675A (en) * 1973-03-16 1975-10-01 Allen & Hanburys Ltd Amides derived from quinoxaline
US4217453A (en) * 1978-07-24 1980-08-12 Merck & Co., Inc. 6-Amido-3-substituted-amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
GR72941B (fi) * 1978-10-20 1984-01-16 Lilly Co Eli
US4224336A (en) * 1979-04-17 1980-09-23 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4670553A (en) * 1982-01-04 1987-06-02 E. R. Squibb & Sons, Inc. 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
US4566876A (en) * 1983-03-10 1986-01-28 Clairol Incorporated Meta-phenylenediamine coupler compounds and oxidative hair dye compositions and methods using same
US4610824A (en) * 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
US4743685A (en) * 1985-09-26 1988-05-10 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
FI872879A (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
US5037983A (en) * 1988-05-16 1991-08-06 E. R. Squibb & Sons, Inc. 6,7-dihydroxyquinoxalines as intermediates to beta-lactam antibiotics
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
CA2024282A1 (en) * 1989-09-21 1991-03-22 Peter H. Ermann Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
US5030724A (en) * 1990-01-22 1991-07-09 E. R. Squibb & Sons, Inc. Monobactam hydrazides containing catechol sulfonic acid groups
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics

Also Published As

Publication number Publication date
MX9101767A (es) 1992-07-08
PL167312B1 (pl) 1995-08-31
JP3157565B2 (ja) 2001-04-16
CN1113228A (zh) 1995-12-13
ZA918014B (en) 1992-07-29
MY113385A (en) 2002-02-28
DK0484881T3 (da) 1999-10-18
KR100228469B1 (ko) 2000-03-15
DE69131090D1 (de) 1999-05-12
JP2000239246A (ja) 2000-09-05
CA2053359A1 (en) 1992-05-06
CZ289671B6 (cs) 2002-03-13
FI915194A (fi) 1992-05-06
FI915194A0 (fi) 1991-11-04
JPH04283579A (ja) 1992-10-08
CN1159303C (zh) 2004-07-28
US5705645A (en) 1998-01-06
AU8694191A (en) 1992-05-07
GR3030572T3 (en) 1999-10-29
NZ280077A (en) 1997-01-29
NZ272438A (en) 1997-01-29
HU211402B (en) 1995-11-28
EP0484881A3 (en) 1992-10-14
CN1061414A (zh) 1992-05-27
NZ272437A (en) 1997-01-29
NZ240382A (en) 1997-01-29
CA2053359C (en) 2004-01-13
IL118368A (en) 1997-09-30
IL118368A0 (en) 1996-09-12
CN1067053C (zh) 2001-06-13
JP3299734B2 (ja) 2002-07-08
ES2129397T3 (es) 1999-06-16
IL99829A0 (en) 1992-08-18
SK282124B6 (sk) 2001-11-06
HUT59921A (en) 1992-07-28
NZ260513A (en) 1997-01-29
YU175791A (sh) 1994-01-20
PT99427A (pt) 1992-09-30
US5420277A (en) 1995-05-30
US5290929A (en) 1994-03-01
MY107454A (en) 1995-12-30
EP0484881A2 (en) 1992-05-13
KR100221505B1 (ko) 2000-03-15
AU659780B2 (en) 1995-05-25
CN1251836A (zh) 2000-05-03
EP0484881B1 (en) 1999-04-07
DE69131090T2 (de) 1999-09-23
IL118367A0 (en) 1996-09-12
UY23318A1 (es) 1992-04-24
ATE178604T1 (de) 1999-04-15
KR100210631B1 (ko) 1999-07-15
PL292287A1 (en) 1992-06-01
KR920009827A (ko) 1992-06-25
NO914320D0 (no) 1991-11-04
AU648835B2 (en) 1994-05-05
IE913565A1 (en) 1992-05-22
KR100248590B1 (en) 2000-03-15
HU913462D0 (en) 1992-01-28
NO914320L (no) 1992-05-06
CS334591A3 (en) 1992-05-13
CN1031825C (zh) 1996-05-22
AU6889294A (en) 1994-10-06

Similar Documents

Publication Publication Date Title
IL99829A (en) Heteroaroyl derivatives of monocyclic beta-lactams pharmaceutical compositions containing the same and processes for the preparation thereof
IL84917A0 (en) Quinolinone derivative,its preparation and pharmaceutical compositions containing it
AU3699193A (en) Pharmaceutical composition containing quinoline and quinazoline derivatives and novel compounds therefor
IL86080A0 (en) Bicyclic compounds,processes for preparation thereof and pharmaceutical composition comprising the same
EP0481756A3 (en) Benzamide derivatives
EP0399626A3 (en) Substituted tetrahydroisoquinoline compounds, their production, and pharmaceutical compositions containing them
HU912216D0 (en) Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them
GB8830226D0 (en) Novel compounds
GB8801899D0 (en) Antibiotic a42867 derivative
AU1523488A (en) Thiadiazole guanidines
FI933928A (fi) Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel
ATE74604T1 (de) Substituierte pyrimidochinoxaline.
ZA869742B (en) Novel pregnane derivatives,processes for their preparation and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees